YDES
YD Bio Ltd.

169
Loading...
Loading...
News
all
press releases
News Placeholder
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal
YD Bio trades under YDES following the Breeze merger, with a pipeline that spans cancer detection and eye disease therapies.
Stocktwits·1mo ago

Latest YDES News

View

Advertisement|Remove ads.

Advertisement|Remove ads.